| Hawaii Island Healthcare Inc | |
|
75 Puuhonu Pl Ste 205 Hilo HI 96720-2000 | |
| (808) 969-3814 | |
| (808) 934-7496 |
| Full Name | Hawaii Island Healthcare Inc |
|---|---|
| Speciality | Family Medicine |
| Location | 75 Puuhonu Pl Ste 205, Hilo, Hawaii |
| Authorized Official Name and Position | Kevin Kurohara (PRESIDENT) |
| Authorized Official Contact | 8089693814 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Hawaii Island Healthcare Inc 75 Puuhonu Pl Ste 205 Hilo HI 96720-2000 Ph: (808) 969-3814 | Hawaii Island Healthcare Inc 75 Puuhonu Pl Ste 205 Hilo HI 96720-2000 Ph: (808) 969-3814 |
| NPI Number | 1730657826 |
|---|---|
| Provider Enumeration Date | 11/06/2018 |
| Last Update Date | 10/17/2022 |
| Medicare PECOS PAC ID | 2961748595 |
|---|---|
| Medicare Enrollment ID | O20190117003498 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Irritable bowel syndrome (IBS) is a chronic relapsing gastrointestinal disorder, and is predominant in younger and middle-aged adults. IBS gradually declines with increasing age of the population, according to GlobalData, a leading data and analytics company.
Today it seems about everything has been shown to lead to heart disease. Of course smoking is bad for you, as is high blood pressure. There's even mounting evidence that psychosocial factors can cause heart problems.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Older adults left in the wake of Hurricane Sandy will likely suffer disproportionately in the days ahead, based on data from other recent natural disasters.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730657826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Kevin K Kurohara |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1578519229 PECOS PAC ID: 2466478284 Enrollment ID: I20051020001074 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Irritable bowel syndrome (IBS) is a chronic relapsing gastrointestinal disorder, and is predominant in younger and middle-aged adults. IBS gradually declines with increasing age of the population, according to GlobalData, a leading data and analytics company.
Today it seems about everything has been shown to lead to heart disease. Of course smoking is bad for you, as is high blood pressure. There's even mounting evidence that psychosocial factors can cause heart problems.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Older adults left in the wake of Hurricane Sandy will likely suffer disproportionately in the days ahead, based on data from other recent natural disasters.
› Verified 3 days ago
| Provider Name | Sheareen Gedayloo |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1801840525 PECOS PAC ID: 6002919420 Enrollment ID: I20070305000652 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Irritable bowel syndrome (IBS) is a chronic relapsing gastrointestinal disorder, and is predominant in younger and middle-aged adults. IBS gradually declines with increasing age of the population, according to GlobalData, a leading data and analytics company.
Today it seems about everything has been shown to lead to heart disease. Of course smoking is bad for you, as is high blood pressure. There's even mounting evidence that psychosocial factors can cause heart problems.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Older adults left in the wake of Hurricane Sandy will likely suffer disproportionately in the days ahead, based on data from other recent natural disasters.
› Verified 3 days ago
| Provider Name | Olivia D Kapono |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1902240245 PECOS PAC ID: 6608164272 Enrollment ID: I20161013002498 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Irritable bowel syndrome (IBS) is a chronic relapsing gastrointestinal disorder, and is predominant in younger and middle-aged adults. IBS gradually declines with increasing age of the population, according to GlobalData, a leading data and analytics company.
Today it seems about everything has been shown to lead to heart disease. Of course smoking is bad for you, as is high blood pressure. There's even mounting evidence that psychosocial factors can cause heart problems.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Older adults left in the wake of Hurricane Sandy will likely suffer disproportionately in the days ahead, based on data from other recent natural disasters.
› Verified 3 days ago
| Provider Name | Amy A Hanapi |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1871108167 PECOS PAC ID: 4284044777 Enrollment ID: I20201112001655 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Irritable bowel syndrome (IBS) is a chronic relapsing gastrointestinal disorder, and is predominant in younger and middle-aged adults. IBS gradually declines with increasing age of the population, according to GlobalData, a leading data and analytics company.
Today it seems about everything has been shown to lead to heart disease. Of course smoking is bad for you, as is high blood pressure. There's even mounting evidence that psychosocial factors can cause heart problems.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Older adults left in the wake of Hurricane Sandy will likely suffer disproportionately in the days ahead, based on data from other recent natural disasters.
› Verified 3 days ago
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced the closing of a previously announced sale of an aggregate of $10 million of securities in a registered direct offering. Rexahn received net proceeds of approximately $9.28 million after deducting placement agent fees and other offering expenses.
Irritable bowel syndrome (IBS) is a chronic relapsing gastrointestinal disorder, and is predominant in younger and middle-aged adults. IBS gradually declines with increasing age of the population, according to GlobalData, a leading data and analytics company.
Today it seems about everything has been shown to lead to heart disease. Of course smoking is bad for you, as is high blood pressure. There's even mounting evidence that psychosocial factors can cause heart problems.
Avanir Pharmaceuticals, Inc. today announced that PRIME, its phase II clinical trial of the investigational drug AVP-923 (dextromethorphan / quinidine) for the treatment of central neuropathic pain in patients with multiple sclerosis did not meet the primary efficacy endpoint.
Older adults left in the wake of Hurricane Sandy will likely suffer disproportionately in the days ahead, based on data from other recent natural disasters.
› Verified 3 days ago
Rainbow Healthcare Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 43 E Lanikaula St, Hilo, HI 96720 Phone: 808-238-4922 | |
Carlos R. Abeyta Md, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 82 Puuhonu Pl, Suite 206, Hilo, HI 96720 Phone: 808-969-9888 Fax: 808-969-9881 | |
Joyful Living, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1248 Kinoole St, Suite 101, Hilo, HI 96720 Phone: 808-935-8398 | |
Administration Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 450 Kilauea Ave Ste 105, Hilo, HI 96720 Phone: 808-961-4071 Fax: 808-961-5678 | |
Craig Y. Shikuma, M.d., Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 82 Puuhonu Pl, Suite 207, Hilo, HI 96720 Phone: 808-935-5522 Fax: 808-961-5058 | |
J Nohea Kaawaloa Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 670 Ponahawai St, Suite 220, Hilo, HI 96720 Phone: 808-933-1120 Fax: 808-933-1125 | |
Big Island Family Medicine Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 670 Ponahawai St Ste 207, Hilo, HI 96720 Phone: 808-365-5988 Fax: 808-365-5989 |